跳至主要内容
临床试验/KCT0003860
KCT0003860招募中未知

Comparison of Dexamethasone and Celecoxib for Prophylaxis for Transcatheter Arterial Chemoembolization : A Randomized Prospective Open-label Multi-center Trial

Chonnam National University Hospital Hwasun Hospital0 个研究点目标入组 216 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
216

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
18(Year) 至 o Limit(—)
性别
All

入选标准

  • A patient who was diagnosed with hepatocellular carcinoma in Chonnam National University Hospital, Chosun University Hospital, and Kwangju Christian Hospital and who had undergone carotid embolization.
  • - Diagnosis of hepatocellular carcinoma: Findings of 1 cm or more found in high risk hepatocellular carcinoma (liver cirrhosis, chronic hepatitis B, chronic hepatitis C with advanced fibrosis or liver cirrhosis)
  • A) Typical imaging findings (arteriovenous enhancement and portal or delayed clearing phenomenon) on dynamic contrast enhanced CT or dynamic contrast enhanced MRI
  • In the case of nodules with no typical imaging findings, secondary imaging findings (moderate signal intensity on MRI T2-weighted images, high signal intensity on diffusion-weighted images, low signal intensity on BACs, Mosaic pattern, nodule within the nodule, fat in the mass, or bleeding) is appropriate
  • - age 18 or older
  • - Persons with liver function preserved
  • - Carotid embolization using Doxorubicin
  • - Those with serum creatinine less than 1.5 mg / d

排除标准

  • - Those who did not agree with the study
  • - Those under 18 years of age
  • - Those with underlying diseases such as cancer of other organs other than liver cancer, advanced heart disease, advanced renal disease
  • - Carotid artery embolization, hepatectomy or systemic chemotherapy
  • - Those with a grade 1 or higher fever, anorexia, nausea / vomiting, etc. at the base
  • - Those with active bacterial infection (who have been treated with antibiotics within 1 week of diagnosis)
  • - Those with human immunodeficiency virus (HIV) infection
  • - Those with uncontrolled diabetes (HbA1c = 8.0g / dL)
  • - Those with autoimmune hepatitis
  • - Those who are positive for HBV DNA but do not take hepatitis B drugs (antiviral drugs)
  • - Those with extrahepatic or microvascular involvement
  • - Those who were taking steroids or anti-inflammatory drugs at random.
  • Those who have hypersensitivity to -COX2-inhibitors
  • - Gastrointestinal bleeding diagnosed or suspected

研究者

发起方
Chonnam National University Hospital Hwasun Hospital

相似试验